G. O'Regan

发表

A. Irvine, G. O’Regan, W. McLean, 2008, The Journal of allergy and clinical immunology.

Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms

James T. Elder, C. Gieger, M. Nöthen, 2015, American journal of human genetics.

Deletion of Late Cornified Envelope 3B and 3C genes is not associated with atopic dermatitis.

D. Postma, X. Estivill, G. Koppelman, 2010, The Journal of investigative dermatology.

Genetics (AAGC) (2015). Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis.

Weidinger, M. Jarvelin, C. Gieger, 2015 .

Delineating Capillary Malformations in the Operating Suite Using White Eyeliner Pencil

G. O’Regan, L. Benjamin, G. O'Regan, 2011, Pediatric dermatology.

Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris

S. Bale, D. Goudie, C. Munro, 2006, Nature Genetics.

Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis

David M. Evans, M. Jarvelin, C. Gieger, 2015, Nature Genetics.

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

Colin N A Palmer, Ann Sergeant, Hans Bisgaard, 2006, Nature Genetics.

The role of filaggrin in the atopic diathesis

A. Irvine, G. O’Regan, G. M. O'Regan, 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk.

C. Strobl, N. Klopp, T. Illig, 2008, The Journal of allergy and clinical immunology.

Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema

Colin N A Palmer, Robert Gruber, C. Palmer, 2007, Nature Genetics.

Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis.

D. Goudie, Yiwei Zhao, A. Irvine, 2006, The Journal of investigative dermatology.

The role of filaggrin loss-of-function mutations in atopic dermatitis

A. Irvine, G. O’Regan, G. O'Regan, 2008, Current opinion in allergy and clinical immunology.

A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis

L. Liang, J. Kere, S. Heath, 2013, Human molecular genetics.

Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations

A. Munnich, D. Figarella-Branger, S. Küry, 2015, Orphanet Journal of Rare Diseases.

Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis

G. Barton, N. Schurch, C. Cole, 2014, The Journal of allergy and clinical immunology.

Chromosome 11q13.5 variant associated with childhood eczema: An effect supplementary to filaggrin mutations

H. Cordell, A. Irvine, G. O’Regan, 2010, The Journal of allergy and clinical immunology.

Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea.

M. Raffeld, S. Pittaluga, S. Rosenzweig, 2017, Blood.

Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity

S. Kežić, A. Irvine, G. O’Regan, 2011, Allergy.

Recent advances in the pathobiology and management of Kasabach–Merritt phenomenon

A. Irvine, G. O’Regan, O. Smith, 2015, British journal of haematology.

Sweet’s syndrome in association with common variable immunodeficiency

M. Keogan, G. Murphy, G. O’Regan, 2009, Clinical and experimental dermatology.

Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center

A. Irvine, V. Dvorakova, G. O’Regan, 2017, Pediatric dermatology.

South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin

S. Kežić, Y. Wen, A. Irvine, 2014, The Journal of allergy and clinical immunology.

Filaggrin in atopic dermatitis.

A. Irvine, G. O’Regan, W. McLean, 2009, The Journal of allergy and clinical immunology.

Raman profiles of the stratum corneum define 3 filaggrin genotype–determined atopic dermatitis endophenotypes

Gerwin J. Puppels, Peter J. Caspers, G. Puppels, 2010, The Journal of allergy and clinical immunology.

Atopic dermatitis and skin disease Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis

N. Schurch, C. Cole, A. Sherstnev, 2022 .

Response to IL‐1‐Receptor Antagonist in a Child with Familial Cold Autoinflammatory Syndrome

A. Irvine, G. O’Regan, R. Watson, 2007, Pediatric dermatology.

The role of filaggrin loss-of-function mutations in atopic dermatitis

A. Irvine, G. O'Regan, 2008, Current opinion in allergy and clinical immunology.

Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis

Manuel A. R. Ferreira, M. Jarvelin, C. Gieger, 2015, Nature Genetics.

Mediastinal and Neck Kaposiform Hemangioendothelioma: Report of Three Cases

M. Sheridan-Pereira, A. Irvine, A. O'marcaigh, 2009, Pediatric dermatology.

Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency

S. Kežić, P. Fallon, P. Caspers, 2012, The Journal of allergy and clinical immunology.

Possibilities for human skin characterization based on strongly reduced Raman spectroscopic information

G. Puppels, A. Irvine, T. Schut, 2013 .

Generalized lymphatic anomaly successfully treated with long‐term, low‐dose sirolimus

A. Irvine, V. Dvorakova, D. Rea, 2018, Pediatric dermatology.